Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Dartmouth College | OTHER |
Not provided
Not provided
Not provided
Not provided
This feasibility pilot study is designed to learn whether patients and their care partners (e.g., family members) are willing and able to complete two study visits at Dartmouth College while receiving cancer care at Dartmouth-Hitchcock Medical Center.
A feasibility pilot open label, single-arm observational case series of 10 patients with metastatic gastrointestinal and lung cancer patients and 10 care partners. Participants will complete two study visits, separated by approximately 8-16 weeks of usual oncologic care with early integrated specialty palliative care. The palliative care physician will also be a study participant.
Primary Objective: To develop and refine study procedures which can be used in future research in order to further understanding of the mechanisms of action of specialty palliative. Expected products: manual of operating procedures and web-based data collection forms.
Secondary Objectives: To test the feasibility of conducting a mechanism-focused clinical trial of primary palliative care vs. specialty palliative care for advanced cancer patients and their care partners. Expected products: preliminary data demonstrating the feasibility of study procedures sufficient to prove this study design is possible.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Arm 1 | Experimental | Patients and care partners receive specialty primary care and participate in pre- and post- functional MRI scans to measure the effects of the specialty palliative care intervention. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Specialty Palliative Care | Other | Specialty palliative care, as opposed to primary palliative care. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Operationalization as measured by the creation of a manual of operating procedures and web-based data collection forms | Establish acceptable operating procedures and data collection instruments which can be replicated for future projects. | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Feasibility as measured by participant interest | Percent of participants approached and interested in participating | 6 months |
| Feasibility as measured by enrollment number | Percent of participants approached and enrolled |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Amber Barnato, MD | Dartmouth-Hitchcock Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03756 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 42183384 | Derived | Fanouraki E, Knotts JD, Page CA, Perry A, Wager TD, Wheatley TP, Ahern C, Barnato AE. Neural Correlates of Palliative Care: A Feasibility Trial in Patients with Metastatic Gastrointestinal and Lung Cancer. Res Sq [Preprint]. 2026 May 11:rs.3.rs-9215484. doi: 10.21203/rs.3.rs-9215484/v1. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005770 | Gastrointestinal Neoplasms |
| D008175 | Lung Neoplasms |
| ID | Term |
|---|---|
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 6 months |
| Feasibility as measured by willingness to be randomized | Percent of participants enrolled and willing to be randomized | 6 months |
| Feasibility as measured by procedure completion rate | Percent of participants randomized and completed procedures (specialty palliative care, fMRIs, surveys, bio response measurements). | 6 months |
| Feasibility as measured by participant withdrawal rate | Percent of participants not completing each study visit and specialty primary care visit | 6 months |
| Tolerability as measured by subjective units of distress scores (SUDS, 0-100) | The SUDs Rating Scale, or Subjective Units of Distress Scale (SUDs) as it is officially known, is used to measure the intensity of distress or nervousness in people with social anxiety. The SUDs is a self-assessment tool rated on a scale from 0 to 100. | 6 months |
| Tolerability as measured by rates of study procedure non-completion. | Percent of participants not completing each study procedures (specialty palliative care, fMRIs, surveys, bio response measurements). | 6 months |
| Acceptability as measured by response to questions of level of burden. | Two closed-ended Likert scale items regarding study burdensomeness. (this investigator-created instrument is in development) | 6 months |
| Acceptability as measured by willingness to recommend study participation to others. | Measured by the Net Promoter Score - The Net Promoter Score is an index that measures the willingness of participants to recommend a services to others. It is used as a proxy for gauging overall satisfaction with a service. Net Promoter Score (scale from 0 to 10 with 3 groups: promoters for 9-10, passive for 7-8 and detractor for below 6). | 6 months |
| D005767 |
| Gastrointestinal Diseases |
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |